Protocol for measuring anti-fentanyl antibodies in mouse serum by enzyme-linked immunosorbent assay
- PMID: 39645655
- PMCID: PMC11667700
- DOI: 10.1016/j.xpro.2024.103402
Protocol for measuring anti-fentanyl antibodies in mouse serum by enzyme-linked immunosorbent assay
Abstract
Enzyme-linked immunosorbent assay (ELISA) offers an effective, inexpensive, and reliable approach for the analysis of humoral immune responses. Here, we describe a protocol for measuring anti-fentanyl antibodies generated by the immunization of mice with novel opioid vaccine candidates. We describe steps for coating BSA-fentanyl antigen and standard wells. We then detail procedures for preparing buffers and performing assays. This protocol is adaptable for use with either BALB/c or C57BL/6J mice strains and can measure antibody isotypes to elucidate class switching. For complete details on the use and execution of this protocol, please refer to Stone et al.1.
Keywords: antibody; cell biology; immunology.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests D.S., O.L., and D.J.D. are named inventors on vaccine adjuvant patents assigned to Boston Children’s Hospital. O.L. has served as a paid consultant to GlaxoSmithKline (GSK) and HilleVax. D.J.D. is on the scientific advisory board of EdJen BioTech and serves as a consultant with Merck Research Laboratories/Merck Sharp & Dohme Corp (a subsidiary of Merck & Co., Inc.). D.J.D., O.L., and C.N.H. are cofounders and sit as scientific advisors of Ovax, Inc. E.B.N. is a scientific advisor to Ovax, Inc. These commercial or financial relationships are unrelated to the current study. C.N.H. is named as an inventor on a patent for anti-fentanyl vaccine assigned to the University of Houston.
Figures
References
-
- Stone A.E., Scheuermann S.E., Haile C.N., Cuny G.D., Velasquez M.L., Linhuber J.P., Duddupudi A.L., Vigliaturo J.R., Pravetoni M., Kosten T.A., et al. Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge. NPJ Vaccines. 2021;6:69. doi: 10.1038/s41541-021-00329-0. - DOI - PMC - PubMed
-
- United States Drug Enforcement Agency. 2024. Controlled Substances Alphabetical Order. July 2024.https://deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf
-
- Conrad B. ”%CV in ELISA: How to Reduce Them and Why They’re Important.” TechNotes. 2023. 2018. https://www.enzolifesciences.com/science-center/technotes/2018/january/c...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
